Skip to main content
manuel-mayr

Professor Manuel Mayr

British Heart Foundation Professor of Cardiovascular Proteomics

Research interests

  • Cardiovascular

Biography

Manuel Mayr qualified in Medicine from the University of Innsbruck (Austria) in 1999. He then moved to London to undertake a PhD. Upon completion of his PhD, he achieved promotion to Professor in 2011. He has been awarded a prestigious British Heart Foundation Personal Chair in 2017. His academic achievements have been recognised by the inaugural Michael Davies Early Career Award of the British Cardiovascular Society (2007), the inaugural Bernard and Joan Marshall Research Excellence Prize of the British Society for Cardiovascular Research (2010), and the Outstanding Achievement Award by the European Society of Cardiology Council for Basic Cardiovascular Science (2013).

    Research

    Vascular Proteomics 780x450
    Vascular Proteomics

    Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes.

    OILRIG
    Lipids and Membranes Research Interest Group

    A Lipids and Membranes Research Interest Group

    News

    Researchers from King's identify new potential molecular mechanism in obesity

    This study identifies neuronal growth regulator 1 (Negr1) as a factor that promotes neuronal growth and protects from the excessive fat accumulation...

    Adipose fat canva newsletter

    Beta-blockers reduce heart proteoglycan content potentially providing newly discovered health benefits

    Researchers discover that beta-blockers can prevent build-up of proteoglycans, a group of proteins that accumulate in the heart of patients with heart failure.

    Cardiac cell SEM colour 780x440

    Protein identified as new therapeutic anti-viral target for COVID-19

    New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new...

    covid-visual

    Quest for biomarkers in blood samples of COVID-19 patients to better understand host response

    Researchers from the School of Cardiovascular Medicine & Sciences have been analysing blood samples of patients with a confirmed COVID-19 diagnosis to better...

    Blood samples COVID-19

      Research

      Vascular Proteomics 780x450
      Vascular Proteomics

      Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes.

      OILRIG
      Lipids and Membranes Research Interest Group

      A Lipids and Membranes Research Interest Group

      News

      Researchers from King's identify new potential molecular mechanism in obesity

      This study identifies neuronal growth regulator 1 (Negr1) as a factor that promotes neuronal growth and protects from the excessive fat accumulation...

      Adipose fat canva newsletter

      Beta-blockers reduce heart proteoglycan content potentially providing newly discovered health benefits

      Researchers discover that beta-blockers can prevent build-up of proteoglycans, a group of proteins that accumulate in the heart of patients with heart failure.

      Cardiac cell SEM colour 780x440

      Protein identified as new therapeutic anti-viral target for COVID-19

      New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new...

      covid-visual

      Quest for biomarkers in blood samples of COVID-19 patients to better understand host response

      Researchers from the School of Cardiovascular Medicine & Sciences have been analysing blood samples of patients with a confirmed COVID-19 diagnosis to better...

      Blood samples COVID-19